BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2685476)

  • 21. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
    Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
    Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
    Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL
    Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction.
    Han JY; Theil KS
    Cancer Genet Cytogenet; 2006 Feb; 165(1):70-4. PubMed ID: 16490599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
    Rudolph C; Hegazy AN; von Neuhoff N; Steinemann D; Schröck E; Stripecke R; Klein C; Schlegelberger B
    Cancer Genet Cytogenet; 2005 Aug; 161(1):51-6. PubMed ID: 16080957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Reardon DA; Hanson CA; Roth MS; Castle VP
    Cancer; 1994 Mar; 73(5):1526-32. PubMed ID: 8111722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of phosphotyrosine in bcr-abl-positive cells with PY20 antibody and its clinical applications].
    Zhu HH; Liu YR; Qin YZ; Chang Y; Li JL; Ruan GR; Jiang B; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):441-4. PubMed ID: 17147244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of "biphenotypic" acute leukemia cell lines with a variant Ph translocation t(9;22;10) (q34;q11;q22).
    Ariyasu T; Matsuo Y; Harashima A; Nakamura S; Takaba S; Tsubota T; Orita K
    Hum Cell; 1998 Mar; 11(1):43-50. PubMed ID: 9710720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
    Radich JP; Kopecky KJ; Boldt DH; Head D; Slovak ML; Babu R; Kirk J; Lee A; Kessler P; Appelbaum F
    Leukemia; 1994 Oct; 8(10):1688-95. PubMed ID: 7934164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome.
    Reboursiere E; Chantepie S; Gac AC; Reman O
    Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):28-33. PubMed ID: 25300567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late-appearing Philadelphia chromosome in childhood acute myeloid leukemia.
    Shah N; Leaker MT; Teshima I; Baruchel S; Abdelhaleem M; Ye CC
    Pediatr Blood Cancer; 2008 May; 50(5):1052-3. PubMed ID: 18213712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Late appearance of Philadelphia chromosome with bcr gene rearrangement in an acute myelocytic leukemia patient].
    Takechi M; Tanaka K; Sigeta C; Oguma N; Kamada N; Kyo T; Dohi H
    Rinsho Ketsueki; 1989 Dec; 30(12):2225-9. PubMed ID: 2695664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase positive acute lymphoblastic leukemia cell lines, NALM-30, NALM-31 and NALM-32, carrying Philadelphia chromosome with biphenotypic characteristics.
    Matsuo Y; Sugimoto A; Harashima A; Nishizaki C; Drexler HG; Orita K
    Hum Cell; 1998 Dec; 11(4):221-30. PubMed ID: 10363160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
    Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
    Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.